(31.03.2020) Interesting publication by Ana Weidenauer et al. in Translational Psychiatry, principal investigator Matthaeus Willeit: Patients with schizophrenia have higher levels of dopamine and the typical symptoms of the disease have been linked to this. However, it is not only the elevated level of the neurotransmitter dopamine that triggers symptoms in patients but also poorer regulation of dopamine release by a certain area of the brain. For the first time, this has now been demonstrated by MedUni Vienna scientists.
» more
back to: Allgemeine Psychiatrie